Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Gastric Cancer × relatlimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 16 Neoplasms 4 Stomach Neoplasms 3 Recurrence 3 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Advanced Cancer 3 Uveal Melanoma 2 Squamous Cell Carcinoma of Head and Neck 2 Multiple Myeloma 2 Colonic Neoplasms 2 Carcinoma, Hepatocellular 2 Turcot syndrome 1 Tertiary Lymphoid Structures 1 Spinocerebellar Degenerations 1 Skin Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Nasopharyngeal Carcinoma 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Microsatellite Unstable Colorectal Cancer 1 Microsatellite Instability 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 Locally Advanced Melanoma 1

Interventions

Paclitaxel 9 apatinib 7 Oxaliplatin 6 Capecitabine 6 camrelizumab 5 S 1 (combination) 4 Cisplatin 4 Fluorouracil 3 130-nm albumin-bound paclitaxel 3 titanium silicide 2 Leucovorin 2 Drug Therapy 2 Docetaxel 2 vorolanib 1 spartalizumab 1 rucaparib 1 relatlimab 1 raltitrexed 1 pazopanib 1 olaparib 1 lobaplatin 1 linrodostat 1 ezogabine 1 endostar protein 1 durvalumab 1 dacomitinib 1 capivasertib 1 Sunitinib 1 Ramucirumab 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02935634 2023-06-09

FRACTION-GC

Bristol-Myers Squibb

Phase 2 Completed

190 enrolled 25 charts

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡